206 related articles for article (PubMed ID: 23762837)
1. Craniosynostosis-associated Fgfr2(C342Y) mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation.
Liu J; Kwon TG; Nam HK; Hatch NE
Biomed Res Int; 2013; 2013():292506. PubMed ID: 23762837
[TBL] [Abstract][Full Text] [Related]
2. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
Liu J; Nam HK; Wang E; Hatch NE
Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of
Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
[TBL] [Abstract][Full Text] [Related]
4. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and Fgfr2 Mutations in Mice.
Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
[TBL] [Abstract][Full Text] [Related]
5. Genetic background dependent modifiers of craniosynostosis severity.
Dudakovic A; Nam HK; Wijnen AJV; Hatch NE
J Struct Biol; 2020 Dec; 212(3):107629. PubMed ID: 32976998
[TBL] [Abstract][Full Text] [Related]
6. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
[TBL] [Abstract][Full Text] [Related]
7. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
8. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
9. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Yes-Associated Protein on the Interaction Between the MEK/Extracellular Signal-Regulated Kinase and Hippo Pathways in Osteoblasts Co-Cultured With Fibroblast Growth Factor Receptor 2-Mutated Dura Cells.
Dong X; Zhang M; Li C; Lai C; Song G; Jin X
J Craniofac Surg; 2022 Jun; 33(4):1250-1254. PubMed ID: 36041089
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the
Peskett E; Kumar S; Baird W; Jaiswal J; Li M; Patel P; Britto JA; Pauws E
Biol Open; 2017 Feb; 6(2):223-231. PubMed ID: 28069589
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling.
Miraoui H; Oudina K; Petite H; Tanimoto Y; Moriyama K; Marie PJ
J Biol Chem; 2009 Feb; 284(8):4897-904. PubMed ID: 19117954
[TBL] [Abstract][Full Text] [Related]
13. Dura cells in the etiopathogenesis of Crouzon syndrome: the effects of FGFR2 mutations in the dura cells on the proliferation of osteoblasts through the hippo/YAP mediated transcriptional regulation pathway.
Dong XH; Zhang MZ; Lai CZ; Li CC; Du L; Song GD; Zong XL; Jin XL
Am J Transl Res; 2021; 13(10):11255-11270. PubMed ID: 34786056
[TBL] [Abstract][Full Text] [Related]
14. Mandibular dysmorphology due to abnormal embryonic osteogenesis in FGFR2-related craniosynostosis mice.
Motch Perrine SM; Wu M; Stephens NB; Kriti D; van Bakel H; Jabs EW; Richtsmeier JT
Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31064775
[TBL] [Abstract][Full Text] [Related]
15. Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice.
Shin HR; Kim BS; Kim HJ; Yoon H; Kim WJ; Choi JY; Ryoo HM
J Cell Physiol; 2022 Apr; 237(4):2155-2168. PubMed ID: 35048384
[TBL] [Abstract][Full Text] [Related]
16. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
[TBL] [Abstract][Full Text] [Related]
17. Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects.
Maeno T; Moriishi T; Yoshida CA; Komori H; Kanatani N; Izumi S; Takaoka K; Komori T
Bone; 2011 Oct; 49(4):673-82. PubMed ID: 21807129
[TBL] [Abstract][Full Text] [Related]
18. FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome.
Wang Y; Liu Y; Chen H; Liu X; Zhang Y; Wang Y; Gu Y
Cells; 2022 Oct; 11(19):. PubMed ID: 36231091
[TBL] [Abstract][Full Text] [Related]
19. Inducible Activation of FGFR2 in Adult Mice Promotes Bone Formation After Bone Marrow Ablation.
Xu W; Luo F; Wang Q; Tan Q; Huang J; Zhou S; Wang Z; Sun X; Kuang L; Jin M; Su N; Jiang W; Chen L; Qi H; Zhu Y; Chen B; Chen H; Chen S; Gao Y; Xu X; Deng C; Chen L; Xie Y; Du X
J Bone Miner Res; 2017 Nov; 32(11):2194-2206. PubMed ID: 28650109
[TBL] [Abstract][Full Text] [Related]
20. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]